John Jed Kennedy Power - 02 Nov 2021 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Group Executive Vice President
Signature
Sarah M. Oliker for John (Jed) Kennedy by Power of Attorney
Issuer symbol
CNMD
Transactions as of
02 Nov 2021
Net transactions value
-$747,153
Form type
4
Filing time
04 Nov 2021, 15:36:51 UTC
Previous filing
31 Aug 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $36,144 +862 +12% $41.93 8,237 02 Nov 2021 Direct
transaction CNMD Common Stock Sale $126,428 -862 -10% $146.67 7,375 02 Nov 2021 Direct F1
transaction CNMD Common Stock Options Exercise $305,796 +5,100 +69% $59.96 12,475 02 Nov 2021 Direct
transaction CNMD Common Stock Sale $267,938 -1,822 -15% $147.06 10,653 02 Nov 2021 Direct F2
transaction CNMD Common Stock Sale $483,734 -3,278 -31% $147.57 7,375 02 Nov 2021 Direct F3
transaction CNMD Common Stock Options Exercise $141,768 +1,800 +24% $78.76 9,175 02 Nov 2021 Direct
transaction CNMD Common Stock Sale $136,891 -928 -10% $147.51 8,247 02 Nov 2021 Direct F4
transaction CNMD Common Stock Sale $129,329 -872 -11% $148.31 7,375 02 Nov 2021 Direct F5
transaction CNMD Common Stock Options Exercise $166,073 +1,700 +23% $97.69 9,075 02 Nov 2021 Direct
transaction CNMD Common Stock Sale $252,613 -1,700 -19% $148.60 7,375 02 Nov 2021 Direct F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -862 -15% $0.000000 5,000 02 Nov 2021 Common Stock 862 $41.93 Direct F7
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -5,100 -32% $0.000000 10,800 02 Nov 2021 Common Stock 5,100 $59.96 Direct F7
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -1,800 -24% $0.000000 5,700 02 Nov 2021 Common Stock 1,800 $78.76 Direct F8
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -1,700 -18% $0.000000 7,600 02 Nov 2021 Common Stock 1,700 $97.69 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.24 to $147.01. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.34 to $147.31. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.36 to $147.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.94 to $147.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.02 to $148.59. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.10 to $148.82. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F7 The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F8 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period